Bay Area's DNAnexus Scores $58M to Accelerate Expansion
The cash will support expansion in translational informatics, clinical trials, and broadened use of biomedical data. Source: BioSpace
2 Underappreciated Biotech Stocks to Buy in 2018
A look at two biopharma companies that fall into this category that investors should check out. Source: BioSpace
Former Pfizer CEO's Boston Startup Centrexion Lands $67M for Ph3 Osteoarthritis Pain Drug
Centrexion closed on a Series D financing worth $67M to develop its knee osteoarthritis drug in Phase III. Source: BioSpace
3 Biotechs Seeking $271M IPO in the New Year
Three biotech companies want to start out the new year with a new start. Source: BioSpace
Optinose Gets $100M Debt Financing From Athyrium Capital Management
At closing of the agreement, $75 million in aggregate principal amount of the Senior Secured Notes were issued. Source: BioSpace
Arrogance and Greed: Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit
From around 2014 through 2016, Valeant seemingly had a crisis story per week, ranging from insider trading to channel stuffing Source: BioSpace
FDA Cites Indian Drugmaker for Sterility, Testing Issues
The FDA flagged a Shilpa Medicare facility in Telangana, India for numerous violations including noncompliant labeling, sterility procedures and testing methods. Source: Drug Industry Daily
New Jersey Firm Warned for Quality Deficiencies
C.O. Truxton drew a warning letter from the FDA for drug repackaging, labeling, complaint handling and product distribution. Source: Drug Industry Daily
ClinicalTrials.gov Receives New Update Allowing Better Geographic Searches
ClinicalTrials.gov received a new set of usability updates last month, including additional local search functions, a new glossary feature and redesigned study record pages. Source: Drug Industry Daily
DEA Proposes to Place Fentanyl Products in Schedule I
The Drug Enforcement Administration proposed listing fentanyl products as Schedule I controlled substances to help address the opioid crisis. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- …
- 610
- Go to the next page